Cargando…

Covid-19: Why test? Who to test? How to test?

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academie nationale de medecine 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218348/ https://www.ncbi.nlm.nih.gov/pubmed/32406424 http://dx.doi.org/10.1016/j.banm.2020.05.006

Ejemplares similares

Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?
por: Preston, Rebecca, et al.
Publicado: (2017)

Who Tests, Who Doesn't, and Why? Uptake of Mobile HIV Counseling and Testing in the Kilimanjaro Region of Tanzania
por: Ostermann, Jan, et al.
Publicado: (2011)

Doctors who pilot the GMC's Tests of Competence: who volunteers and why?
por: Mehdizadeh, Leila, et al.
Publicado: (2014)

From Lab-Testing to Web-Testing in Cognitive Research: Who You Test is More Important than how You Test
por: Uittenhove, Kim, et al.
Publicado: (2023)

Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease: Why and Who to Test
por: van Ommen, C. Heleen, et al.
Publicado: (2017)

Sex steroid priming in short stature children unresponsive to GH stimulation tests: Why, who, when and how
por: Partenope, Cristina, et al.
Publicado: (2022)

Five-year monitoring of a gay-friendly voluntary counselling and testing facility in Switzerland: who got tested and why?
por: Gumy, Cédric, et al.
Publicado: (2012)

Testing of how and why the Terpios hoshinota sponge kills stony corals
por: Syue, Siang-Tai, et al.
Publicado: (2021)

Intracerebral hemorrhage: who gets tested for methamphetamine use and why might it matter?
por: Osman, Sahar, et al.
Publicado: (2020)

COVID-19: Test, Test and Test
por: Saleh, Fatima A, et al.
Publicado: (2020)

A pilot study of PCR community mass testing for COVID-19: who attends and who tests positive?
por: Levin, Kate, et al.
Publicado: (2021)

Germline TP53 Testing in Breast Cancers: Why, When and How?
por: Evans, D. Gareth, et al.
Publicado: (2020)

Who is accessing community lateral flow device testing and why? Characteristics and motivations of individuals participating in COVID-19 community testing in two English local authority areas
por: Dalili, Michael N., et al.
Publicado: (2022)

Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
por: Lippi, Giuseppe, et al.
Publicado: (2021)

The early test catches the case. Why wait? Frequent testing of close contacts aids COVID-19 control
por: Walsh, J., et al.
Publicado: (2021)

Covid‐19 will not “magically disappear”: Why access to widespread testing is paramount
por: George, Paul E., et al.
Publicado: (2020)

Why and how we should join the shift from significance testing to estimation
por: Berner, Daniel, et al.
Publicado: (2022)

When, how and why BRCA1 and BRCA2 genetic testing is offered to patients who do not meet standard criteria
por: Duffy, J, et al.
Publicado: (2012)

Covid‐19 Control and the Economy: Test, Test, Test
por: Taamouti, Abderrahim
Publicado: (2021)

Who's gonna test your tests ? Mutants !
por: WITOWSKI, Sebastian
Publicado: (2015)

Subgroup analysis and interaction tests: why they are important and how to avoid common mistakes
por: Ferreira, Juliana Carvalho, et al.
Publicado: (2017)

1783. More than Which Molecular Test: Following the Directions in How and Who to Test in the Diagnosis of Influenza
por: Mayer, Jeanmarie, et al.
Publicado: (2019)

Why Only Test Symptomatic Patients? Consider Random Screening for COVID-19
por: Padula, William V.
Publicado: (2020)

Significance testing: Why does it prevail?
por: Ahlbom, Anders
Publicado: (2017)

Antibody tests for diagnosing COVID-19: how relevant are they?
por: Shey, Muki Shehu, et al.
Publicado: (2020)

Biomarker testing in MCI patients—deciding who to test
por: van Maurik, Ingrid S., et al.
Publicado: (2021)

Why Did Students Report Lower Test Anxiety during the COVID-19 Pandemic?
por: Ewell, Sharday N., et al.
Publicado: (2022)

Assessment of patients who tested positive for COVID-19 after recovery
por: Mei, Qi, et al.
Publicado: (2020)

Uninformative and unuseful: why it is necessary to actively challenge COVID-19 antibody testing postvaccination
por: Romero-Alvarez, D., et al.
Publicado: (2021)

‘Test, re-test, re-test’: using inaccurate tests to greatly increase the accuracy of COVID-19 testing
por: Ramdas, Kamalini, et al.
Publicado: (2020)

Modeling the optimization of COVID-19 pooled testing: How many samples can be included in a single test?
por: Liu, Lu
Publicado: (2022)

Why‐not‐doing‐high‐tech‐test Syndrome
por: Mizumoto, Junki, et al.
Publicado: (2020)

Why Inject Beam During the Sector Test?
por: Assmann, R W
Publicado: (2003)

New COVID-19 saliva-based test: How good is it compared with the current nasopharyngeal or throat swab test?
por: Hung, Kai-Feng, et al.
Publicado: (2020)

Antigen-detecting rapid tests or real-time PCR, what test to use and why?()
por: Revollo Barriga, Boris, et al.
Publicado: (2021)

The “Defibrillation Testing, Why Not?” survey. Testing of subcutaneous and transvenous defibrillators in the Italian clinical practice()
por: Migliore, Federico, et al.
Publicado: (2022)

Community Vs. hospital HIV testing sites in Jerusalem, Israel - who’s tested and who’s at risk?
por: Atias, Dor, et al.
Publicado: (2020)

How COVID-19 Is Testing and Evolving Our Communication Skills
por: Julka-Anderson, Naman
Publicado: (2020)

How to interpret and use COVID-19 serology and immunology tests
por: Ong, David S.Y., et al.
Publicado: (2021)

Testing COVID-19 tests faces methodological challenges
por: Bossuyt, Patrick M.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n8dk3t51sbihmtfrrmj44ddflk